LITCHMAN MANUEL MD (President and CEO) purchased 18.0% of their position (100K shares) of MUSTANG BIO, INC. on the open market
Open‑market purchase worth $291.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/22/2020ACC: 0001104659-20-138581
DirectorOfficer· President and CEO
Since Nov 2018
+166K
Net shares
Net buyer
$303.4K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
166K acquired
Non-Derivative Transactions3
COMMON STOCK
Direct
Shares
+5K
Price / share
$2.48
Trade value
$12.40K
% of position
1.0%
8/31/2020
488.85K→493.85K
COMMON STOCK
Direct
Shares
+61K
Price / share
—
Trade value
—
% of position
12.4%
9/15/2020
493.85K→554.85K
COMMON STOCK
Direct
Shares
+100K
Price / share
$2.91
Trade value
$291K
% of position
18.0%
12/15/2020
554.85K→654.85K
Total
Net shares
+166K
Net value
$303.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 8/31/2020 | A · Award | +5K | $2.48 | $12.40K | 1.0% | 488.85K | 493.85K |
| COMMON STOCK Direct | 9/15/2020 | A · Award | +61K | — | — | 12.4% | 493.85K | 554.85K |
| COMMON STOCK Direct | 12/15/2020 | P · Purchase | +100K | $2.91 | $291K | 18.0% | 554.85K | 654.85K |
| Total | +166K | $303.40K | ||||||
Derivative Transactions0
No derivative transactions reported